Biotech · Private company
Immunogenics, LLC
Track this companyFree. Adds Immunogenics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- LatiglutenasePhase 2 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of Latiglutenase in T1D/CD PatientsPHASE2 · TERMINATED · started Apr 6, 2021ClinicalTrials.gov NCT04839575 · fetched Nov 12, 2026
- Latiglutenase as a Treatment for Celiac DiseasePHASE2 · COMPLETED · started Mar 1, 2019ClinicalTrials.gov NCT03585478 · fetched Nov 12, 2026
- Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]EARLY_PHASE1 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT03011931 · fetched Nov 12, 2026